Who We Fund
Since 1949, LLS has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who’ve joined our fight to find cures and help blood cancer patients everywhere.

Marco Ruella
Immunotherapy for T-cell lymphoma

Daisuke Nakada
preleukemia, leukemia

Ramon Massoni-Badosa
CLL and Richter's Syndrome

Jenny Wang
AML

Amit Verma
AML/MDS

Jianhua Yu
myeloma immunotherapy

Peter Croucher
Multiple Myeloma

Sham Mailankody
Myeloma immunotherapy clinical trials

Joachim Yahalom
Lymphoma

Jaehyuk Choi
T-cell lymphoma

Anushree Vichare
Equity in Access

Margaret Shipp
lymphoma biology

Kathleen Sakamoto
pediatric AML

Michael Wang
Mantle Cell Lymphoma

Coleman Lindsley
AML/MDS

Courtney Jones
AML metabolism

Affimed
immunotherapy, HL, PTCL

Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia

Anouchka Laurent
T-cell lymphoma

Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL

Nicolas Nassar
pediatric leukemia

Yiman Liu
Epigenetics and leukemia

Venkata Lokesh Battula
immunotherapy and AML

Jeremy Baeten
AML

Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL

Peter Klein
MDS

John Crispino
myelofibrosis, pediatric leukemia and Downs

Michael Savona
MDS and leukemia

Christopher Flowers
clinical trial access

Armin Rashidi
gut bacteria and transplant success

Jonathan Licht
DNA biology, myeloma

Paul Beavis
immunotherapy in myeloma

Auron Therapeutics
degrader, AML, MDS

Simona Colla
Myeloma biology

Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML

Jeffrey Magee
pediatric AML

Jonathon Cohen
lymphoma clinical trial access in Georgia

Tycel Phillips
Mantle Cell Lymphoma

Gianpietro Dotti
CAR T and AML

Jennifer Amengual
lymphomas after transplant

Daniel Lucas
bone marrow and leukemia biology

Rajni Kumari
AML

Britta Will
Leukemia and pre-leukemia

Jing Yang
Myeloma

Constantine Mitsiades
CAR-T and CAR-NK immunotherapies

Suzanne Lentzsch
Myeloma

Dimericon Therapeutics
dimericons, blood cancer

Michael Keller
COVID-19, immunotherapy

Brian Dalton
DNA mutations and myeloid cancers

Ryvu Therapeutics
AML, MDS, Myelofibrosis

Dan Landau
cancer evolution biology

Lori Muffly
Equity in Access

Sahand Hormoz
MPN

Wendy Béguelin
follicular lymphoma

Jing Fu
myeloma

Lei Ding
myeloproliferative neoplasms, myelofibrosis

Enterome
vaccine, FL, MZL

Roland Walter
Antibody-based AML therapies

Jennifer Woyach
CLL trials

Riccardo Dalla-Favera
lymphoma (DLBCL)

Richard Lock
T-ALL

Yibin Yang
Lymphoma

H. Irene Su
Equity in Access

Steven Treon
Lymphomas and Waldenstrom's

Nataly Cruz-Rodriguez
T-ALL and metabolism

Mendel Goldfinger
MDS/AML trials for the elderly

Justine Kahn
pediatric leukemia and lymphoma

Philippe Armand
follicular lymphoma

Alfred Garfall
myeloma immunotherapy

Suman Paul
T cell cancers and immunotherapy

Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM

Catherine Diefenbach
DLBCL immunology

Solu Therapeutics
immunotherapy, CMML

Alex Kentsis
pediatric leukemias

Eugenio Morelli
Myeloma

Christian Marinaccio
MLL leukemias

Carl June
CAR T immunotherapy

Elliot Stieglitz
CMML

Paola Aguilar Neuville
Primary cutaneous γδ T-cell lymphoma

Huda Salman
CMML

Takeshi Sugio
T-cell lymphoma

Matteo Bellone
Smoldering multiple myeloma

Liling Wan
AML

Dane Vassiliadis
blood cancer biology

Meng Li
Equity in Access

Qing Yi
Novel CAR-T

Thomas LeBlanc
palliative care

Jeetayu Biswas
splicing in myeloid diseases

Thomas Kipps
Hairy Cell Leukemia

Daphne Friedman
Equity in Access

Rachel Mersfelder
AMKL

BioInvent International
immunotherapy, indolent NHL, CTCL

F. Lennie Wong
Equity in Access

Pooja Khandelwal
bone marrow transplantation

Cailin Collins
Leukemia and pre-leukemia

Timothy Graubert
AML and MDS biology

Piers Patten
COVID-19

Mala Shanmugam
myeloma

Constellation Pharmaceuticals
myeloproliferative neoplasms

Anthony Letai
improving CAR-T

Brian Walker
smoldering myeloma, MGUS

Helen Parsons
Equity in Access

Bingyi Chen
AML immunotherapy

Eirini Papapetrou
blood cancer stem cells

Shannon Maude
Immunotherapy for ALL

Michaela Reagan
Multiple Myeloma

Craig Jordan
AML

Yoke Seng Lee
AML

Madhav Dhodapkar
multiple myeloma immunotherapy

George Daley
"off-the-shelf" CAR-T and CAR-NK

Kimberly Stegmaier
childhood blood cancers

Christine Zhang
AML

Daniel Thomas
Myelofibrosis

Yan Liu
MDS

Nicola Vannini
Aging and CAR-T success

Tanya Siddiqi
clinical trial access

Caner Saygin
T-ALL

Nizar Bahlis
Myeloma immunotherapy

Sergei Doulatov
Leukemias

Stacie Dusetzina
Equity in Access

Carma Bylund
Equity in Access

Ravi Bhatia
transplantation

Fahmin Basher
transplant and GvHD

Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial

William Matsui
Myeloma

Robert Soiffer
transplantation

Lawrence Boise
CART and myeloma

Carl Allen
pediatric blood cancers

Rgenta Therapeutics
RNA-targeting, blood cancer

Maximilian Stahl
AML immunotherapy

Tomasz Skorski
myeloproliferative neoplasms, AML

Steven Horwitz
T-cell lymphomas

Roberta Zappasodi
lymphoma, immunotherapy

Catherine Smith
leukemia

Jayna Mistry
aging and leukemias

Matthew Frank
Lymphoma CART therapy

Sigurður Kristinsson
Smoldering myeloma

Hao Jiang
DNA biology and leukemia

Keisuke Ito
blood cancer stem cells and MDS metabolism

Jane Oliaro
Myeloma & Lymphoma Immunotherapy

Nitin Jain
CLL

ImCheck Therapeutics
immunotherapy, AML

Wendy Stock
T-cell ALL

Caroline Arber
myeloma CAR-T

Rong Lu
preleukemia, leukemia

Jennifer Trowbridge
aging and leukemia

Daniel Pollyea
AML

Jalpa Doshi
Equity in Access

Jianguo Tao
Mantle Cell Lymphoma

Fenghuang Zhan
Myeloma and bone disease

Teresa Palomero
Peripheral T-cell Lymphoma

Robert Orlowski
(Smoldering) Multiple Myeloma

Marc Seifert
Hairy cell leukemia

Mark Hamilton
DLBCL and CAR-T

Paolo Strati
Non-Hodgkin Lymphoma

Qingyu Luo
BPDCN

Noemí Puig Morón
Myeloma

Adi Nagler
Bronchiolitis obliterans after transplant

Michael Kharas
leukemia

Ravindra Majeti
preleukemia, AML

Siddhartha Jaiswal
preleukemia

Alieen Rowan
Adult T cell leukemia/lymphoma

Sheng Li
Aging and AML

Julia Maxson
AML

Urvi Shah
Diet and myeloma

Hong Wen
AML

Enrico Tiacci
Hairy cell leukemia

Nicoletta Cieri
AML and transplantation

Steven Park
follicular lymphoma

Marina Konopleva
MDS/AML metabolism

Yubin Zhou
peripheral T cell lymphoma

Shazia Nakhoda
Equity in Access

Christopher Porter
Leukemia, lymphoma

Paolo Caimi
CAR-T clinical trial for CLL

Kerry Rogers
CLL

Markus Muschen
leukemia and lymphoma biology

Manyi Wei
acute megakaryoblastic leukemia

Reina Takeda
AML

Eric Pietras
AML

Sriram Sundaravel
AML stem cells

Liran Shlush
pre-leukemia

Bing Carter
p53 mutant AML

Adam de Smith
pediatric ALL and Down Syndrome

Jonas Jutzi
myeloproliferative neoplasms

Stephen Nimer
myeloid cancer biology

Rizwan Romee
Immunotherapy

Gaurav Goyal
Erdheim-Chester Disease

Andrew Lane
BPDCN

Immune-Onc Therapeutics
immunotherapy, AML, CMML

Bruno Paiva
smoldering myeloma

Catherine Bollard
pediatric blood cancers and immunotherapy

Ricky Johnstone
lymphoma and myeloma

Bailee Kain
AML and African ancestry

Eric Padron
CMML

Nirav Shah
CAR-T for lymphoma

Tak Mak
Immunotherapy

Kasey Leger
pediatric blood cancers

Stephen Gottschalk
pediatric leukemia and CAR-T

Taishi Yonezawa
AML

Leandro Cerchietti
DLBCL

Faron Pharmaceuticals
immunotherapy, MDS

Anita Kumar
Mantle Cell Lymphoma immunotherapy

Ruben Carrasco
Myeloma

Michael Green
lymphoma biology

Siegfried Janz
Myeloma immunotherapy

Raymond Mailhot
Equity in Access

Jun Qi
Myeloma

Megan McNerney
AML/MDS

James Rubenstein
Lymphoma of the Central Nervous System

Ronald Levy
immunotherapies, COVID-19

Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's

Sarah Tasian
pediatric leukemias

Lev Kats
myeloma and epigenetics

Neha Mehta-Shah
T-cell lymphoma

Julia Paczkowska
immunobiology of Hodgkin's disease

Koichi Takahashi
AML/MDS

Jake Shortt
precision therapy for aggressive lymphomas

Grzegorz Nowakowski
Clinical trial access

Kura Oncology
MLL leukemia, AML

Daniel Herranz
T-ALL

John DiPersio
trispecific antibody for AML and MDS

Courtney DiNardo
clinical trials, AML

Luca Busino
DLBCL

Oreofe Odejide
Equity in Access

Xu Ji
Equity in Access

Lindsey Montefiori
pediatric leukemia

Lucy Godley
preleukemia

Alexey Danilov
lymphoma

Christian Steidl
B-cell lymphomas

Mark Dawson
B-ALL and CAR-T resistance

Saar Gill
AML immunotherapy

Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy

Trent Hall
MDS

Mark Murakami
follicular lymphoma

Frederick Locke
lymphoma and immunotherapy

John Leonard
lymphoma research

Randall Davis
CLL

Thomas Koehnke
leukemia

Ari Melnick
epigenetics and lymphoma

Soheil Meshinchi
pediatric AML

Caron Jacobson
lymphoma and immunotherapy

Ana Vujovic
AML

Jean Koff
Disparities in DLBCL

Catriona Jamieson
cancer stem cell biology

Logan Spector
childhood leukemia epidimiology

Adam Olszewski
Follicular and marginal zone lymphoma

Pietro Genovese
transplant and AML

Grant Challen
preleukemia, leukemia

George Vassiliou
Leukemia Prevention

Srividya Swaminathan
pediatric, immunotherapy

Ann-Kathrin Eisfeld
Racial diversity in AML

Jessica Stewart
Epstein-barr virus and lymphomas

Omar Abdel-Wahab
Hairy cell leukemia

Sam Butterworth
CMML

Inhye Ahn
CLL

Tyler Parsons
MPN and AML

Andrew Hantel
Equity in Access

Jolanta Grembecka
leukemia therapeutics

Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients

Christopher Booth
BPDCN

Martin Dreyling
Mantle Cell Lymphoma

Kirk Schultz
pediatric transplantation